E2F8 and neoplasm: As shown in Figure 1A, E2F8 levels remained low in non-tumor breast tissues but became markedly higher in patients with luminal A and further elevated in other subtypes including luminal B, Basal-like and Her2-enriched, suggesting that E2F8 might contribute to high proliferation rates in breast cancer.